News

Thu 14 Mar 2024
AI for Healthcare panel at the Pharma.be General Assembly
Kantify was invited at the pharma.be special panel on AI for Healthcare
Mon 11 Mar 2024
Poster at ESMO : AI for target and drug discovery in sarcoma
Kantify will share its latest results on rapid identification of novel targets and polypharmacological compounds for liposarcoma treatment, thanks to AI
Mon 11 Dec 2023
Kantify at Belgium's Biopharmaceutical Excellence Conference
Kantify shared some of its groundbreaking work at the Conference on the Belgian biopharmaceutical sector organized by the Federal Ministry of Foreign Affairs
Thu 07 Dec 2023
Appointment of Dr Eckhard von Keutz as Scientific Advisor
Kantify appoints Dr von Keutz, former Vice-President at Bayer Pharmaceuticals, as Scientific Advisor
Wed 29 Nov 2023
Kantify will use its AI platform to tackle 5 rare diseases
Kantify is selected by the European Commission to perform an unprecedented research project on rare diseases and AI
Thu 05 Oct 2023
Kantify speaking at Slush'D Leuven
Kantify will be speaking in the panel on "AI: redefining business or enhancing roles"
Tue 19 Sep 2023
TV debate on the impact of AI on human thought
Kantify was invited to discuss about AI's impact on human thought
Thu 24 Aug 2023
Kantify speaking at the 6th TPD Summit in Boston
Join Kantify's Session at the 6th TPD Summit: Unveiling the Power of AI in Protein Degradation
Thu 15 Jun 2023
Presentation at Cafes de L'Innovation
Kantify is invited to present its work on AI for target identification and small molecule prediction at Institut Bordet
Mon 12 Jun 2023
Event: How AI is changing the game in drug discovery
Kantify is presenting its work on AI based drug discovery at an event where Insilico Medicine, Microsoft, and others will also be present
Tue 06 Jun 2023
Kantify Nominated as Early Startup to Watch by Sifted
We are featured in Sifted's report "AI-Driven Drug Discovery 2.0" Market Report
Mon 22 May 2023
Pitch and Meet at the Tech.eu Summit
Kantify has been selecting to pitch at the Tech.eu Summit 2023 and will present Zeptomics, its solution for AI powered small molecule discovery